Literature DB >> 18341394

Cell therapies for traumatic brain injury.

Matthew T Harting1, James E Baumgartner, Laura L Worth, Linda Ewing-Cobbs, Adrian P Gee, Mary-Clare Day, Charles S Cox.   

Abstract

Preliminary discoveries of the efficacy of cell therapy are currently being translated to clinical trials. Whereas a significant amount of work has been focused on cell therapy applications for a wide array of diseases, including cardiac disease, bone disease, hepatic disease, and cancer, there continues to be extraordinary anticipation that stem cells will advance the current therapeutic regimen for acute neurological disease. Traumatic brain injury is a devastating event for which current therapies are limited. In this report the authors discuss the current status of using adult stem cells to treat traumatic brain injury, including the basic cell types and potential mechanisms of action, preclinical data, and the initiation of clinical trials.

Entities:  

Mesh:

Year:  2008        PMID: 18341394      PMCID: PMC3721356          DOI: 10.3171/FOC/2008/24/3-4/E17

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  78 in total

1.  Experimental traumatic brain injury modulates the survival, migration, and terminal phenotype of transplanted epidermal growth factor receptor-activated neural stem cells.

Authors:  John A Boockvar; Joost Schouten; Nicolas Royo; Marie Millard; Zak Spangler; Debbie Castelbuono; Evan Snyder; Donald O'Rourke; Tracy McIntosh
Journal:  Neurosurgery       Date:  2005       Impact factor: 4.654

2.  Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement.

Authors:  E M Horwitz; K Le Blanc; M Dominici; I Mueller; I Slaper-Cortenbach; F C Marini; R J Deans; D S Krause; A Keating
Journal:  Cytotherapy       Date:  2005       Impact factor: 5.414

Review 3.  Mesenchymal stem cells: progress toward promise.

Authors:  K Le Blanc; Mf Pittenger
Journal:  Cytotherapy       Date:  2005       Impact factor: 5.414

4.  Cytokine-induced stable neuronal differentiation of human bone marrow mesenchymal stem cells in a serum/feeder cell-free condition.

Authors:  Helen Tao; Renuka Rao; David D F Ma
Journal:  Dev Growth Differ       Date:  2005-08       Impact factor: 2.053

5.  Delayed transplantation of human neurons following brain injury in rats: a long-term graft survival and behavior study.

Authors:  Chen Zhang; Kathryn E Saatman; Nicolas C Royo; Kristie M Soltesz; Marie Millard; Joost W Schouten; Melissa Motta; Rachel C Hoover; Asenia McMillan; Deborah J Watson; Virginia M-Y Lee; John Q Trojanowski; Tracy K McIntosh
Journal:  J Neurotrauma       Date:  2005-12       Impact factor: 5.269

6.  Infusion of human umbilical cord blood ameliorates neurologic deficits in rats with hemorrhagic brain injury.

Authors:  Zhenhong Nan; Andrew Grande; Cyndy D Sanberg; Paul R Sanberg; Walter C Low
Journal:  Ann N Y Acad Sci       Date:  2005-05       Impact factor: 5.691

7.  Transplantation of a novel cell line population of umbilical cord blood stem cells ameliorates neurological deficits associated with ischemic brain injury.

Authors:  Jing Xiao; Zhenhong Nan; Yasuhiko Motooka; Walter C Low
Journal:  Stem Cells Dev       Date:  2005-12       Impact factor: 3.272

8.  Neural cell differentiation in vitro from adult human bone marrow mesenchymal stem cells.

Authors:  Xiaoxiao Long; Marie Olszewski; Wei Huang; Morris Kletzel
Journal:  Stem Cells Dev       Date:  2005-02       Impact factor: 3.272

9.  Human marrow stromal cell treatment provides long-lasting benefit after traumatic brain injury in rats.

Authors:  Asim Mahmood; Dunyue Lu; Changsheng Qu; Anton Goussev; Michael Chopp
Journal:  Neurosurgery       Date:  2005-11       Impact factor: 4.654

Review 10.  Cognitive outcome in traumatic brain injury survivors.

Authors:  Claire Helen Salmond; Barbara Jacquelyn Sahakian
Journal:  Curr Opin Crit Care       Date:  2005-04       Impact factor: 3.687

View more
  18 in total

Review 1.  Angiogenesis, neurogenesis and brain recovery of function following injury.

Authors:  Ye Xiong; Asim Mahmood; Michael Chopp
Journal:  Curr Opin Investig Drugs       Date:  2010-03

2.  An update from the United States National Heart, Lung, and Blood Institute-funded Production Assistance for Cellular Therapies (PACT) program: a decade of cell therapy.

Authors:  Deborah Wood; Robin Wesselschmidt; Peiman Hematti; Adrian P Gee; Cliona Rooney; Leslie Silberstein; Myriam Armant; Larry Couture; John E Wagner; David H McKenna; Derek Hei; Traci Heath Mondoro; Lisbeth Welniak; Robert Lindblad
Journal:  Clin Transl Sci       Date:  2014-03-21       Impact factor: 4.689

3.  Extracellular Vesicles Mediate Neuroprotection and Functional Recovery after Traumatic Brain Injury.

Authors:  Min Kyoung Sun; Austin P Passaro; Charles-Francois Latchoumane; Samantha E Spellicy; Michael Bowler; Morgan Goeden; William J Martin; Philip V Holmes; Steven L Stice; Lohitash Karumbaiah
Journal:  J Neurotrauma       Date:  2020-02-10       Impact factor: 5.269

4.  Safety of neural stem cell transplantation in patients with severe traumatic brain injury.

Authors:  Zhigang Wang; Yong Luo; Lvan Chen; Wu Liang
Journal:  Exp Ther Med       Date:  2017-05-04       Impact factor: 2.447

5.  Diffuse white matter response in trauma-injured brain to bone marrow stromal cell treatment detected by diffusional kurtosis imaging.

Authors:  Lian Li; Michael Chopp; Guangliang Ding; Esmaeil Davoodi-Bojd; Qingjiang Li; Asim Mahmood; Ye Xiong; Quan Jiang
Journal:  Brain Res       Date:  2019-04-19       Impact factor: 3.252

6.  Neural progenitor cell transplantation promotes neuroprotection, enhances hippocampal neurogenesis, and improves cognitive outcomes after traumatic brain injury.

Authors:  Meghan O Blaya; Pantelis Tsoulfas; Helen M Bramlett; W Dalton Dietrich
Journal:  Exp Neurol       Date:  2014-12-04       Impact factor: 5.330

7.  Enhancing neural stem cell response to SDF-1α gradients through hyaluronic acid-laminin hydrogels.

Authors:  C P Addington; J M Heffernan; C S Millar-Haskell; E W Tucker; R W Sirianni; S E Stabenfeldt
Journal:  Biomaterials       Date:  2015-08-25       Impact factor: 12.479

Review 8.  Cell therapy for CNS trauma.

Authors:  K K Jain
Journal:  Mol Biotechnol       Date:  2009-03-28       Impact factor: 2.695

9.  Mesenchymal stem cells for treatment of CNS injury.

Authors:  Michael F Azari; Louisa Mathias; Ezgi Ozturk; David S Cram; Richard L Boyd; Steven Petratos
Journal:  Curr Neuropharmacol       Date:  2010-12       Impact factor: 7.363

10.  A clinical trial report of autologous bone marrow-derived mesenchymal stem cell transplantation in patients with spinal cord injury.

Authors:  Pu-Cha Jiang; Wen-Ping Xiong; Ge Wang; Chao Ma; Wei-Qi Yao; Steven F Kendell; Brian M Mehling; Xian-Hou Yuan; Dong-Cheng Wu
Journal:  Exp Ther Med       Date:  2013-04-29       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.